Study on the relationship between polymorphisms of CYP1A1 gene and susceptibility of lung cancer in Sichuan population

Chinese Journal of Lung Cancer

Volumn 7, Issue 1, 2004, Pages 38-42

  Dong, Caiting ^a   Yang, Qing ^a   Jiang, Bin ^a   Dong, Qinian ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CYP1A1; Lung neoplasms; Polymorphism; Susceptibility

Indexed keywords

CYTOCHROME P450 1A; ISOLEUCINE; VALINE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 1342302680     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Li DR, Zhou QH. Advances in studies on genetic susceptibility of lung cancer. Chin J Lung Cancer, 2003, 6 (2): 158-162.
2. Chen SQ, Xu L, Ma JG, et al. Identification of genetic polymorphism of CYP1A1 and GSTM1 in lung cancer patients by using allele-specific PCR and multiplex differential PCR. Carcinog Teratog Mutag, 1999, 11(3): 119-121.
3. Przygodzki RM, Koss MN, O'Leary TJ. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12. Mol Diagn, 2001, 6(2): 109-115.
4. Cheng YW, Hsieh LL, Lin PP, et al. Gender difference in DNA adduct levels among nonsmoking lung cancer patients. Environ Mol Mutagen, 2001, 37(4): 304-310.
5. Cheng YW, Chen CY, Lin P, et al. DNA adduct level in lung tissue may act as a risk biomarker of lung cancer. Eur J Cancer, 2000, 36 (11): 1381-1388.
6. Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res, 1999, 59(14): 3317-3320.
7. Bartsch H, Rojas M, Nair U, et al. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Cancer Detect Prev, 1999, 23(6): 445-453.
8. Rojas M, Cascorbi I, Alexandrov K, et al. Modulation of benzo[a] pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis, 2000, 21(1): 35-41.
9. London SJ, Yuan JM, Coetzee GA, et al. CYP1A1 1462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev, 2000, 9(9): 987-991.